Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGFβ1 transgenic mice |
| |
Authors: | Kai Michaelis Katrin Wallbrecht Andreas Kerstan Niklas Beyersdorf Cortny Williams Thomas Kerkau Xiao‐Jing Wang Thomas Hünig Michael P Schön |
| |
Institution: | 1. Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany;2. Department of Dermatology, Venereology and Allergology, University of G?ttingen, G?ttingen, Germany;3. Department of Dermatology, Venereology and Allergology, University of Würzburg, Würzburg, Germany;4. Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany;5. Department of Pathology, University of Colorado Health Sciences Center, Denver, CO, USA |
| |
Abstract: | Please cite this paper as: Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGFβ1 transgenic mice. Experimental Dermatology 2009; 19: 406–415. Abstract: To use mice with chronic hyperproliferative skin inflammation as psoriasis models, their thorough phenotypic and functional characterization is indispensable. Mice with keratin 5 promoter‐controlled overexpression of latent human Transforming Growth Factor (TGF)β1 within the basal epidermis (K5.TGFβ1 mice) show a psoriasiform phenotype, but the underlying pathogenic mechanisms are not entirely clear. To elucidate the contribution of T lymphocytes to the pathogenesis in K5.TGFβ1 mice, we used three complementary approaches: first, peripheral T cells were eradicated via systemic treatment with CD3‐ or CD4‐depleting antibodies. However, this elimination did not alleviate the chronic inflammatory disorder. Second, bone marrow transplantation from transgenic mice into wildtype recipients and vice versa resulted in the expected reconstitution of both adaptive and innate immune system but had little effect on the cutaneous phenotype both in wildtype and transgenic chimeras. Third, based on the hypothesis that the disease course could be modulated by regulatory T cells (Tregs), we expanded Tregs in vivo using a superagonistic anti‐CD28 antibody. While this treatment achieved a threefold increase in Foxp3‐expressing Tregs, there was little, if any, effect on the chronic skin inflammation. We conclude from our findings that T cells play little, if any, role in the skin lesions of K5.TGFβ1 mice. |
| |
Keywords: | costimulation inflammation psoriasis– regulatory T cells skin T cells TGFβ transgenic mice |
|
|